查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2152423

糖尿病照護臨床營養市場規模、佔有率和趨勢分析報告：按產品、疾病階段、銷售管道、地區和細分市場預測（2026-2033 年）

Clinical Nutrition For Diabetes Care Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

預計到 2025 年，全球糖尿病照護臨床營養市場規模將達到 24 億美元，到 2026 年將擴大到 25 億美元，到 2033 年將達到 35 億美元，2026 年至 2033 年的複合年成長率為 4.8%。

北美市場佔據主導地位，預計2025年將佔全球銷售額的34.0%。糖尿病患者或有患病風險族群對特殊食品的需求不斷成長，是推動糖尿病臨床營養市場成長的關鍵因素。這包括1型或2型糖尿病患者，以及遵循糖尿病飲食的人。

糖尿病盛行率不斷上升，主要受人口老化、肥胖、缺乏運動和不健康飲食習慣等因素驅動，這是全球臨床營養市場成長的主要驅動力。根據國際糖尿病聯盟（IDF）預測，到2024年，全球20至79歲的成年人中約有5.89億人患有糖尿病，約佔全球成年人口的11.1%。預計到2050年，這一數字將達到8.53億，反映出糖尿病對世界帶來的日益沉重的負擔。糖尿病仍然是心血管疾病、慢性腎臟病、失明和下肢截肢等嚴重併發症的主要原因，而人口老化、肥胖、缺乏運動、不良飲食習慣和血糖控制不佳會加劇這些風險。

隨著糖尿病及其併發症的盛行率持續上升，醫療專業人員擴大採用專業的臨床營養干預措施，以支持血糖控制、改善營養狀況並提升患者的長期預後。疾病特異性醫學食品、口服營養補充劑以及腸內和腸外營養在管理營養缺乏和延緩高風險患者的疾病進展方面發揮著至關重要的作用。此外，明尼蘇達大學的一項研究報告稱，新冠疫情后美國2型糖尿病的發生率增加了62%，這一趨勢在10至19歲的兒童和青少年中尤為顯著，凸顯了有效營養管理的日益成長的需求。

消費者意識的提高、公共衛生支持措施的加強以及越來越多的科學證據表明營養在糖尿病管理中發揮重要作用，這些因素進一步推動了對糖尿病專用營養產品的需求。消費者越來越傾向於選擇低糖、低碳水化合物、營養均衡且方便食用的產品，許多人願意為更健康的替代品支付更高的價格。預計消費者偏好的這些轉變將支撐糖尿病臨床營養市場的持續成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：全球糖尿病照護臨床營養市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 全球糖尿病照護臨床營養市場分析工具

第4章：全球糖尿病照護臨床營養市場：按產品分類的估算與趨勢分析

  • 全球糖尿病照護臨床營養市場：產品概覽
  • 全球糖尿病照護臨床營養市場：產品動態分析
  • 分析2021年至2033年全球糖尿病照護臨床營養市場的規模、預測與趨勢（涵蓋以下內容）：
  • 口服營養
  • 靜脈營養
  • 經腸營養

第5章：糖尿病照護臨床營養市場：各階段的估算與趨勢分析

  • 糖尿病照護臨床營養市場：分階段概覽
  • 糖尿病照護臨床營養市場：各階段趨勢
  • 對糖尿病照護臨床營養市場的規模、預測和趨勢（2021-2033 年）進行分析，涵蓋以下項目。
  • 成人
  • 兒童

第6章：全球糖尿病照護臨床營養市場：按銷售管道分類的估算與趨勢分析

  • 全球糖尿病照護臨床營養市場：按銷售管道分類的概覽
  • 全球糖尿病照護臨床營養市場：按銷售管道分類的趨勢分析
  • 對2021年至2033年全球糖尿病照護臨床營養市場的規模、預測和趨勢進行分析（涵蓋以下內容）：
  • 線上
  • 零售
  • 向機構銷售

第7章：全球糖尿病照護臨床營養市場：區域估算與趨勢分析

  • 2025年及2030年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2025
    • Abbott Nutrition
    • Pfizer Inc.
    • Bayer AG
    • Nestle Health Science SA
    • GlaxoSmithKline plc
    • Baxter International Inc.
    • Otsuka Holdings Co., Ltd.
    • Mead Johnson & Company, LLC
    • Danone Nutricia,
    • Victus, Inc.
Product Code: GVR-4-68040-218-7

The global clinical nutrition for diabetes care market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.5 billion in 2026 to USD 3.5 billion by 2033, growing at a CAGR of 4.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.0% in 2025. The increasing demand for specialized food products by individuals with diabetes or those at risk of developing the condition is a critical factor for the diabetes clinical nutrition market growth. This includes people with type 1 or type 2 diabetes, as well as those following a diabetic diet.

The rising prevalence of diabetes, driven by aging, obesity, sedentary lifestyles, and unhealthy dietary habits, is a major factor supporting the growth of the global clinical nutrition market. According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20-79 years were living with diabetes worldwide in 2024, representing around 11.1% of the global adult population. This figure is projected to reach 853 million by 2050, reflecting the increasing global burden of the disease. Diabetes remains a leading cause of serious complications, including cardiovascular disease, chronic kidney disease, blindness, and lower-limb amputations, with risks increasing due to aging, obesity, physical inactivity, poor dietary habits, and inadequate glycemic control.

As the prevalence of diabetes and its associated complications continues to rise, healthcare providers are increasingly incorporating specialized clinical nutrition interventions to support glycemic control, improve nutritional status, and enhance long-term patient outcomes. Disease-specific medical foods, oral nutritional supplements, and enteral and parenteral nutrition play an important role in managing nutritional deficiencies and slowing disease progression in high-risk patients. Furthermore, a study by the University of Minnesota reported a 62% increase in the incidence of type 2 diabetes in the U.S. following the COVID-19 pandemic, particularly among children and adolescents aged 10-19 years, highlighting the growing need for effective nutritional management.

Growing consumer awareness, supportive public health initiatives, and increasing scientific evidence regarding the benefits of nutrition in diabetes management are further driving demand for diabetes-specific nutrition products. Consumers are increasingly seeking low-sugar, low-carbohydrate, and nutritionally balanced products that offer convenience without compromising taste, while many are willing to pay a premium for healthier alternatives. This shift in consumer preferences is expected to support sustained growth in the diabetes clinical nutrition market.

Global Clinical Nutrition for Diabetes Care Market Report Segmentation

This report forecasts revenue growth at the global, country, and regional levels, and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical nutrition for diabetes care market report based on product, stage, sales channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

Oral Nutrition

Parenteral Nutrition

Enteral Feeding Formulas

  • Stage Outlook (Revenue, USD Million, 2021 - 2033)

Adult

Pediatric

  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

Online

Retail

Institutional Sales

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

    • U.S.
    • Canada

Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea

Latin America

    • Brazil
    • Mexico
    • Argentina

Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Stage
    • 1.2.3. Sales Channel
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Stage Outlook
    • 2.2.3. Sales Channel Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Clinical Nutrition for Diabetes Care Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Clinical Nutrition for Diabetes Care Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Global Clinical Nutrition for Diabetes Care Market: Product Estimates & Trend Analysis

  • 4.1. Global Clinical Nutrition for Diabetes Care Market: Product Dashboard
  • 4.2. Global Clinical Nutrition for Diabetes Care Market: Product Movement Analysis
  • 4.3. Global Clinical Nutrition for Diabetes Care Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.4. Oral Nutrition
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Parenteral Nutrition
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Enteral Feeding Formulas
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Clinical Nutrition for Diabetes Care Market: Stage Estimates & Trend Analysis

  • 5.1. Clinical Nutrition for Diabetes Care Market: Stage Dashboard
  • 5.2. Clinical Nutrition for Diabetes Care Market: Stage Movement Analysis
  • 5.3. Clinical Nutrition for Diabetes Care Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.4. Adult
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Pediatric
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Clinical Nutrition for Diabetes Care Market: Sales Channel Estimates & Trend Analysis

  • 6.1. Global Clinical Nutrition for Diabetes Care Market: Sales Channel Dashboard
  • 6.2. Global Clinical Nutrition for Diabetes Care Market: Sales Channel Movement Analysis
  • 6.3. Global Clinical Nutrition for Diabetes Care Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.4. Online
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Retail
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Institutional Sales
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Global Clinical Nutrition for Diabetes Care Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Denmark
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Norway
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. China
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. Thailand
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. Abbott Nutrition
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Pfizer Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bayer AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Nestle Health Science S.A.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. GlaxoSmithKline plc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Baxter International Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Otsuka Holdings Co., Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mead Johnson & Company, LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Danone Nutricia,
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Victus, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global clinical nutrition for diabetes care market, 2021 - 2033 (USD Million)
  • Table 3 Global clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 5 Global clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 6 North America clinical nutrition for diabetes care market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 9 North America clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 10 U.S. clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 12 U.S. clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 13 Canada clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 15 Canada clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 16 Europe clinical nutrition for diabetes care market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 18 Europe clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 19 Europe clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 20 UK clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 21 UK clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 22 UK clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 23 Germany clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 24 Germany clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 25 Germany clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 26 France clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 27 France clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 28 France clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 29 Italy clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 30 Italy clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 31 Italy clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 32 Spain clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 33 Spain clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 34 Spain clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 35 Denmark clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 36 Denmark clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 37 Denmark clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 38 Sweden clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 39 Sweden clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 40 Sweden clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 41 Norway clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 42 Norway clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 43 Norway clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific clinical nutrition for diabetes care market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 48 China clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 49 China clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 50 China clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 51 Japan clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 53 Japan clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 54 India clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 55 India clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 56 India clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 57 Australia clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 58 Australia clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 59 Australia clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 60 Thailand clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 61 Thailand clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 62 Thailand clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 63 South Korea clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 64 South Korea clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 65 South Korea clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 66 Latin America clinical nutrition for diabetes care market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 68 Latin America clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 69 Latin America clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 70 Brazil clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 71 Brazil clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 72 Brazil clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 73 Mexico clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 74 Mexico clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 75 Mexico clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 76 Argentina clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 78 Argentina clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 79 MEA clinical nutrition for diabetes care market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 82 MEA clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 83 South Africa clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 85 South Africa clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 89 UAE clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 91 UAE clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)
  • Table 92 Kuwait clinical nutrition for diabetes care market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait clinical nutrition for diabetes care market, by stage, 2021 - 2033 (USD Million)
  • Table 94 Kuwait clinical nutrition for diabetes care market, by sales channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Clinical nutrition for diabetes care market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Product and stage segment snapshot
  • Fig. 11 Sales channel segment snapshot
  • Fig. 12 Market dynamics
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 PESTLE analysis
  • Fig. 15 Clinical nutrition in diabetes care market: Product outlook and key takeaways
  • Fig. 16 Clinical nutrition in diabetes care market: Product movement analysis
  • Fig. 17 Oral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Parenteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Enteral feeding formulas market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Clinical nutrition in diabetes care market: Stage outlook and key takeaways
  • Fig. 21 Clinical nutrition in diabetes care market: Stage movement analysis
  • Fig. 22 Adult market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Pediatric market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Clinical nutrition in diabetes care market: Sales channel outlook and key takeaways
  • Fig. 25 Clinical nutrition in diabetes care market: Sales channel movement analysis
  • Fig. 26 Online market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Retail market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Institutional sales market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Clinical nutrition in diabetes care market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways (1/2)
  • Fig. 31 Regional marketplace: Key takeaways (2/2)
  • Fig. 32 North America clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 UK clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Germany clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 France clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Italy clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Spain clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Denmark clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Sweden clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Norway clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Asia Pacific clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Japan clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Latin America clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Brazil clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Mexico clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Argentina clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 MEA clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait clinical nutrition in diabetes care market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Company market share analysis, 2023
  • Fig. 89 Strategic framework